Evidence map›Paper›PMID 41053057›Full record

ArticleBlood cancer journal2025

Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.

Andrew Palmer, Garth Rauscher, Alexa Schoen, Madelyn Burkart, Ashley Dunton, Cherry Au, Ami Dave, Ahmad Nassar, Shaoshi Zhu, Alexander O'Hara and 13 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Andrew PalmerUniversity of Chicago Pritzker School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0009-0008-5239-0676
Garth RauscherUniversity of Illinois at Chicago School of Public Health, Chicago, IL, USA.
Alexa SchoenDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Madelyn BurkartAtrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
Ashley DuntonDepartment of Medicine, Rush University, Chicago, IL, USA.
Cherry AuDepartment of Medicine, Rush University, Chicago, IL, USA.
Ami DaveAtrium Health Levine Cancer Institute, Chicago, IL, USA.
Ahmad NassarDivision of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Shaoshi ZhuUniversity of Illinois College of Medicine, Chicago, IL, USA.
Alexander O'HaraDepartment of Medicine, Loyola University Medical Center, Chicago, IL, USA.
Nusrat AfricawalaLoyola University Stritch School of Medicine, Chicago, IL, USA.
Amani ErraDepartment of Hematology Oncology, Northwestern Medical Group, Chicago, IL, USA.
Vinod SolipuramDivision of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.
Ivy AbrahamUniversity of Chicago Medicine, Chicago, IL, USA.
Stephanie B TsaiDivision of Hematology and Oncology, Department of Medicine, Loyola University Medical Center, Chicago, IL, USA.
Maryam ZiaDivision of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.
Melissa L LarsonDivision of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL, USA.
Damiano RondelliDivision of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Jessica K AltmanDepartment of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Wendy StockSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Irum KhanDepartment of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Olatoyosi OdenikeSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Anand Ashwin PatelSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA. anand.patel@bsd.uchicago.edu.ORCID http://orcid.org/0000-0002-0296-8686

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
NIEHS NIH HHS P30 ES027792
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41053057
PMCPMC12501014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.